# APELLIS PHARMACEUTICALS INC NOTE  3.500% 9/1

APELLIS PHARMACEUTICALS INC NOTE  3.500% 9/1 is a security (CUSIP 03753UAB2) tracked across SEC portfolio filings. 7 institutional managers reported $99.2M on Form 13F as of 2026-03-31.

## Summary

- Issuer: APELLIS PHARMACEUTICALS INC
- Class: NOTE  3.500% 9/1
- CUSIP: 03753UAB2
- 13F holders: 7
- 13F value: $99.2M
- 13F period: 2026-03-31
- N-PORT fund positions: 0

## Top institutional holders (Form 13F)

| Manager | Location | Value | Shares |
| --- | --- | --- | --- |
| [DeepCurrents Investment Group LLC](https://search.stillhousedata.com/firm/288159) | NEW YORK, NY | $47.2M | 44,494,000 |
| Linden Advisors LP | New York, NY | $29.6M | 28,138,000 |
| [TENOR CAPITAL MANAGEMENT Co., L.P.](https://search.stillhousedata.com/firm/153277) | NEW YORK, NY | $12.7M | 11,950,000 |
| D. E. Shaw & Co., Inc. | New York, NY | $5.3M | 5,000,000 |
| [WOLVERINE ASSET MANAGEMENT LLC](https://search.stillhousedata.com/firm/138907) | CHICAGO, IL | $3.3M | 3,122,000 |
| CANTOR FITZGERALD, L. P. | NEW YORK, NY | $1.2M | 1,130,000 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | BIRMINGHAM, AL | — | 0 |

## More

- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/security/03753UAB2.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.